Absolutely. The last one that responded saying "this trial is no longer available" (university Chicago) eventually clarified that it was no longer available due to "staffing problems". Others wouldn't clarify. Waiting on a more definitive explanation from St Luke's and hoping it's because it's maxed-out on enrollment. I'm afraid it's not the case however because the clinician gave me the whole thing about it being such a rare cancer and having such a small target of eligible candidates.
News 
Market Data 
Discover 
